WeLeader Biomedical Co., Ltd.
WeLeader Biomedical Co., Ltd. operates as an agent and distributor of in vitro diagnostic products. It offers a range of medical testing systems, such as serum biochemistry integration platform, clinical care, and medical information integration system. The company also provides blood gas electrolyte analyzers, urine analyzers, integrated fully automatic biochemical analyzers, fully automatic ele… Read more
Market Cap & Net Worth: WeLeader Biomedical Co., Ltd. (7713)
WeLeader Biomedical Co., Ltd. (TWO:7713) has a market capitalization of $20.62K (NT$682.13K) as of March 18, 2026. Listed on the TWO stock exchange, this Taiwan-based company holds position #43757 globally and #1942 in its home market, demonstrating a 0.85% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying WeLeader Biomedical Co., Ltd.'s stock price NT$71.60 by its total outstanding shares 9527 (9.53K).
WeLeader Biomedical Co., Ltd. Market Cap History: 2025 to 2026
WeLeader Biomedical Co., Ltd.'s market capitalization history from 2025 to 2026. Data shows growth from $21.14K to $20.62K (0.00% CAGR).
WeLeader Biomedical Co., Ltd. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how WeLeader Biomedical Co., Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7713 by Market Capitalization
Companies near WeLeader Biomedical Co., Ltd. in the global market cap rankings as of March 18, 2026.
Key companies related to WeLeader Biomedical Co., Ltd. by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
WeLeader Biomedical Co., Ltd. Historical Marketcap From 2025 to 2026
Between 2025 and today, WeLeader Biomedical Co., Ltd.'s market cap moved from $21.14K to $ 20.62K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | NT$20.62K | -2.45% |
| 2025 | NT$21.14K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of WeLeader Biomedical Co., Ltd. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.62K USD |
| MoneyControl | $20.62K USD |
| MarketWatch | $20.62K USD |
| marketcap.company | $20.62K USD |
| Reuters | $20.62K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.